Besides, ALDH1A1 and ALDH1A2 have been documented as glioma migration-associated genes (38–40), while ALDH1A1 also participated in GBM resistance to temozolomide (17, 19). This evidence concerns the gene ALDH1A2 and central nervous system cancer.